Benchmark indices climbed to record high levels gaining 0.40% each by the closing bell today, backed by strong global equities after China said it agreed with the US to roll back tariffs imposed during their prolonged trade war. While Sensex made its highest closing at 40,653, Nifty ended above 12K mark at 12,016 for the first time after June 2019, backed by gains in industry heavyweight HDFC.Top Nifty gainers included Sun Pharma, IndusInd Bank, Bharti Infratel, Hindalco Industries and JSW St...

Alok Nanda, CEO, GE India Technology Centre says that often the common problem in driving collaboration at work is even if every individual is given the same goal, they interpret it differently

The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.

GSK Pharma said that it was contacted by regulatory authorities regarding the detection of genotoxic nitrosamine NOMA in ranitidine products.

GSK spokesperson informs that the company has been contacted by the regulatory authorities of different countries, including India, regarding the detection of genotoxic nitrosamine NDMA in ranitidine products

GSK Consumer Healthcare Q1 results: Total income of the company, which owns health foods drink (HFD) brands like Horlicks, Boost, and Maltova, grew 9.74 per cent YoY to Rs 1,320.90 crore in June quarter

Extending losses for the third consecutive session, equity markets ended lower Monday with BSE Sensex closing at 38,031, down 305 points and NSE Nifty ending 82 points down to settle at 11,337, as high selling interest continued in the equity market due to concerns over an economic slowdown and weak corporate earnings hurt the investor's sentiments.\"With Lack of any fresh positive domestic triggers and uncertain global cues, we maintain our cautious stance on the Indian equity ...

Extending losses for the third consecutive session, equity markets ended lower Monday with BSE Sensex closing at 38,031, down 305 points and NSE Nifty ending 82 points down to settle at 11,337.

Failed policies cause domestic manufactures to import medical devices, while the government wants India to list among top five medical devices manufacturing hubs in the world under the 'Make in India' initiative

Earlier in January, GlaxoSmithKline Consumer Healthcare had informed that it has received approval from the fair trade regulator CCI for its merger deal with HUL

BSE Sensex is up 1445.67 points or 3.81 per cent at 39,376.44 and NSE Nifty is trading up by 420.70 or 3.69 per cent at 11,827.85, in the last hour of trade.

Indian pharma companies need to move fast on THE digital highway to stay relevant in the future.

Ramdev in a tweet said, \"For them everything, every emotion is just a commodity. For us parents are next to Gods.\" Ramdev drew parallel with East India Company and called for complete boycott of the foreign company for hurting Hindu sentiments.